March 2, 2021 – Global News
If AstraZeneca isn't widely recommended for seniors, who should get the vaccine?
Dr. Samir Sinha, director of health policy research at the NIA, understands where NACI’s caution is coming from. He said the decision was based on the evidence at hand and with the intention of guiding the best public health response.
“It’s not that NACI is saying, ‘No, these shouldn’t be used in older people,’ they’re just saying, right now, we don’t have enough data to actually recommend its use in people older than 65. And that’s actually congruent with what many European countries have come up with.”